Status:
COMPLETED
Corticosteroids and Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation
Lead Sponsor:
The Nazareth Hospital, Israel
Conditions:
Diabetes
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18+ years
Brief Summary
Corticosteroid treatment in diabetic patients admitted for COPD exacerbation are expected to significantly increase hemoglobin A1C levels
Detailed Description
HbA1C levels were evaluated in diabetic patients with COPD exacerbation on admission to the hospital and 3-months later. Demographic, clinical, laboratory variables and total steroid dose were documen...
Eligibility Criteria
Inclusion
- Diabetic patients with COPD exacerbation
Exclusion
- Patients treated with steroids during the previous 3 months
Key Trial Info
Start Date :
April 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01798420
Start Date
April 1 2012
End Date
October 1 2012
Last Update
February 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of medicine
Nzareth, Nazareth, Israel, 16000